Groundbreaking study on FENBENDAZOLE published: Stage IV cancer patients in REMISSION – no chemo needed

What if you were told you had six months to live. Your oncologist, clad in a crisp white coat, delivers the verdict with the clinical detachment of a man reading a grocery list: “Stage IV. Metastatic. No further options.” The chemotherapy failed. The radiation burned through your body like napalm, leaving only exhaustion and a tumor that laughs at modern medicine. Then, in the quiet desperation of a 3 a.m. Google spiral, you stumble upon a story—no, not just a story, a rebellion—of terminal patients who refused to die on schedule. They didn’t submit to another round of toxic slop pumped into their veins. They didn’t mortgage their homes for a glimmer of false hope in some biotech boardroom’s latest “breakthrough.” Instead, they walked into a farm supply store, plunked down a Lincoln, and bought a bottle of fenbendazole, a dog de-wormer so safe it’s sold over the counter. And then, against every odds, their cancers vanished.

A bombshell peer-reviewed study, published this month in Oncology Research and Treatment, documents three stage IV cancer patients—breast, prostate, and melanoma—who achieved complete or near-complete remission using fenbendazole (FBZ) as their primary treatment. No chemotherapy. No half-million-dollar mRNA “vaccines” from Merck and Moderna. Just a decades-old anti-parasitic, a handful of supplements, and the audacity to believe their bodies could heal without Big Pharma’s permission. The results? An 83-year-old woman, cancer-free for three years. A 75-year-old man, in remission for two. A 63-year-old melanoma patient, clear for nearly a year. Their tumors didn’t just shrink—they disappeared.

Yet in Alberta, Canada, Premier Danielle Smith’s government is criminalizing fenbendazole, lumping it in with ivermectin as “dangerous” drugs unfit for human consumption. Meanwhile, Merck—once the patent holder for ivermectin—is pushing a $500,000 mRNA cancer “vaccine” through clinical trials, a product so lucrative it makes COVID jabs look like a lemonade stand.

Key points:

• Three stage IV cancer patients—breast, prostate, melanoma—achieved remission using fenbendazole (FBZ), a $1 dog de-wormer, with no chemotherapy.
• The 83-year-old breast cancer patient was given months to live in 2021. Today, she’s cancer-free, with no recurrence in three years.
• Fenbendazole works by destabilizing microtubules in cancer cells, starving tumors of glucose, and triggering apoptosis (cellular suicide).
• Big Pharma is suppressing FBZ and ivermectin to protect their high-profit mRNA cancer treatments, including Merck’s $500,000 “vaccine.”
• Alberta, Canada, is banning fenbendazole for human use, while U.S. regulators and medical boards punish doctors who prescribe repurposed drugs.
• The study authors warn: Without clinical trials, patients are forced into underground self-medication—a direct result of regulatory capture by pharmaceutical interests.

The cure they don’t want you to know exists

Let’s start with the science, because the establishment would prefer you believe this is all anecdotal hocus-pocus. Fenbendazole isn’t some back-alley snake oil. It’s a benzimidazole anthelmintic, part of a class of drugs that have been studied for their anticancer properties for decades.

How does it work? Think of cancer as a greedy, gluttonous beast, devouring sugar to fuel its rampage. FBZ cuts off its food supply by disrupting glucose uptake, while simultaneously sabotaging the tumor’s skeleton—its microtubules—so it can’t divide or spread. Then, like a trojan horse, it triggers apoptosis, the cell’s self-destruct sequence. Normal cells? Unharmed. Cancer cells? Annihilated.

This isn’t theory. In 2021, Stanford researchers published a case series of three terminal cancer patients who used FBZ and beat the odds. Now, this new study confirms it: Three more patients, three more miracles. The 83-year-old woman with stage IV breast cancer had metastases in her liver, lungs, and spine. Hospice was her only “option.” She started FBZ in November 2021. By April 2022, her PET scan showed no metabolic activity—no cancer. The 75-year-old man with prostate cancer had bone metastases so aggressive his PSA levels were through the roof. After a year on FBZ? Undetectable PSA. Near-total remission. The 63-year-old melanoma patient, riddled with tumors, saw his circulating tumor DNA plummet from 123.37 to 0 in seven weeks.

And the side effects? “None reported.” No hair loss. No vomiting. No immune system collapse. Just healing.

Yet the medical-industrial complex would rather you die on schedule than risk upsetting their profit margins.

Why Big Pharma would rather let you die than lose a dime

Fenbendazole isn’t just effective—it’s cheap. Painfully, embarrassingly cheap. A bottle costs less than a Starbucks latte. There’s no patent to exploit, no $500,000 price tag to justify. Worse (for them), it works better than their products.

Enter Merck, the same company that once held the patent on ivermectin—another repurposed drug with proven anticancer properties—before abandoning it when the profits dried up. During COVID, Merck actively sabotaged ivermectin, despite studies showing it shrunk tumors in 28 different cancers. Why? Because they’re now partnered with Moderna on an mRNA cancer vaccine that costs half a million dollars per patient. Their first target? Melanoma. The same cancer one of the FBZ patients cured for $1 a day.

This isn’t coincidence. It’s predatory capitalism dressed in a lab coat.

In Alberta, Canada, Premier Danielle Smith’s government is banning fenbendazole for human use, classifying it alongside ivermectin as “dangerous.” Never mind that millions of dogs take it safely every year. Never mind that the only “danger” is to Pharma’s bottom line. Meanwhile, doctors who dare prescribe these drugs—like Dr. Pierre Kory and Dr. Paul Marik—have been stripped of their licenses, fined, and publicly crucified for the crime of saving lives.

The pattern is chillingly consistent:

• A cheap, off-patent drug shows miraculous results in terminal patients.
• Big Pharma suppresses the research, funds hit pieces in medical journals, and lobbies regulators to ban it.
• Governments comply, criminalizing the cure while fast-tracking expensive, unproven alternatives (see: mRNA “vaccines”).
• Patients are left with two choices: Submit to the system or become medical refugees.

This isn’t healthcare. It’s extortion.

The underground railroad for the terminally ill

With regulators and pharmaceutical lackeys blocking access, patients are forced into the shadows. The Fenbendazole Cancer Support Group on Facebook has 110,000 members—desperate people trading dosages, success stories, and warnings about which governments are cracking down. Some drive across state lines to buy it. Others order it from veterinary suppliers under the table. A few brave doctors—those who haven’t been bullied into silence—prescribe it off-label, risking their careers to do what’s right.

And the results? Thousands of anecdotal successes. Stories of stage IV lung cancer patients whose tumors melted away. Pancreatic cancer survivors who were told to get their affairs in order. Leukemia patients in remission after chemotherapy failed.

Yet the FDA once mocked ivermectin with tweets telling people to “stop taking horse medicine.” The Canadian government is now prosecuting doctors who prescribe it. And the media? Crickets. Because if the public realized cancer could be treated for pennies, the entire $200 billion oncology industry would collapse overnight.

Sources include:

Karger.com

Scitechnol.com

X.com